• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: RESHAPE LIFESCIENCES LAP-BAND SYSTEM; ADJUSTABLE GASTRIC BAND

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

RESHAPE LIFESCIENCES LAP-BAND SYSTEM; ADJUSTABLE GASTRIC BAND Back to Search Results
Device Problem Unintended Movement (3026)
Patient Problems Anemia (1706); Erosion (1750); Dysphagia/ Odynophagia (1815); Hemorrhage/Bleeding (1888); Unspecified Infection (1930); Nausea (1970); Pain (1994); Gastrointestinal Regurgitation (4477); Appropriate Clinical Signs, Symptoms, Conditions Term / Code Not Available (4581)
Event Date 04/23/2020
Event Type  malfunction  
Manufacturer Narrative
Investigation is ongoing, and as additional information becomes available including whether or not the devices identified in the published article were lap-band, a supplemental report will be made.At this time, the reported issue will be tracked and trended.A2 age: mean age at removal was 57 years (range, 35-67).D6b: literature author stated the devices were explanted between 2009 and 2019 but didn't specify the exact dates.Erosion group characteristics in the erosion group (n 5 22), 16 (73%) were female.The american society of anesthesiologists class was 2 (range 2-3).Thirteen patients (59%) had obstructive sleep apnea, 11 (50%) had hypertension, 9 (41%) had hyperlipidemia, 7 (32%) had diabetes, and 10 (45%) had gastroesophageal reflux disease.Mean time from placement to removal was 7.2 years (range, 2-12).Mean body mass index at removal was 40 (range, 27.5-58.7).Mean age at removal was 57 years (range, 35-67).Seven patients (32%) underwent laparoscopic removal of the lagb and 14 (64%) underwent endoscopic removal.One patient (4%) underwent combined laparoscopic and endoscopic approach.Presentation and diagnosis of erosion patients who had an eroded lagb presented with a variety of symptoms, including abdominal pain (59%), anemia (9%), dysphagia (36%), gastrointestinal bleeding (9%), port infection (14%), nausea (23%), reflux (18%), and weight regain (27%).One patient was asymptomatic.Workup for diagnosis of band erosion was performed using a variety of modalities.Six patients were diagnosed by computed tomography scan, 3 patients were diagnosed by upper gastrointestinal radiography, and 10 patients were found to have erosion with upper endoscopy.The remaining 3 patients were found to have erosion at the time of surgery and not identified preoperatively.
 
Event Description
Literature review performed: endoscopic removal of eroded laparoscopic adjustable gastric bands: a preferred approach.Todd j.Robinson, d.O.(a), celine soriano, m.D.(a), michael larsen, m.D.(b), mohan k.Mallipeddi, m.D.(a), jeffrey a.Hunter, m.D.(a), lily chang, m.D(a).A.Department of general, thoracic, and vascular surgery, virginia mason medical center, seattle, washington.B.Department of gastroenterology, virginia mason medical center, seattle, washington.Surgery for obesity and related diseases 16 (2020) 1030-1034.This published article described a single-center, retrospective review of a prospectively maintained database to identify patients who underwent lagb removal from 2009 to 2019.The subset of patients with band erosion were identified for the study.The patient characteristics, presenting symptoms, diagnostic modalities and method of band extraction were analyzed.A total of 132 patients underwent lagb removal during the study period, among whom 22 (16.7%) patients were diagnosed with erosion.Seven (32%) patients underwent laparoscopic removal, 14 (64%) patients underwent endoscopic removal, and 1 patient (4%) underwent combined laparoscopic and endoscopic approach.These latter patients had variable amounts of erosion and buckle visibility, but all underwent endoscopic retrieval.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LAP-BAND SYSTEM
Type of Device
ADJUSTABLE GASTRIC BAND
Manufacturer (Section D)
RESHAPE LIFESCIENCES
1001 calle amanecer
san clemente CA 92673
Manufacturer Contact
jazmin quiroz
1001 calle amanener
san clemente, CA 92673
8779377374
MDR Report Key16919739
MDR Text Key315854071
Report Number3013508647-2023-00338
Device Sequence Number1
Product Code LTI
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P000008
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Literature
Reporter Occupation Physician
Type of Report Initial
Report Date 05/12/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/12/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/13/2023
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other; Required Intervention;
Patient Age57 YR
Patient SexFemale
-
-